MYO - Myomo GAAP EPS of -$0.29 beats by $0.13 revenue of $4.04M misses by $0.02M
2023-03-13 09:05:14 ET
- Myomo press release ( NYSE: MYO ): Q4 GAAP EPS of -$0.29 beats by $0.13 .
- Revenue of $4.04M (+0.2% Y/Y) misses by $0.02M .
-
387 patients added to the pipeline in fourth quarter, up 75% compared with Q4 2021
-
“We expect first quarter 2023 product revenue to increase between 15% and 20% compared with the first quarter of 2022, Given the strength of the patient pipeline entering 2023 - now only with reliable payers- we believe full-year product revenue growth of between 20% to 30% is attainable."
- Shares +8.11% PM.
For further details see:
Myomo GAAP EPS of -$0.29 beats by $0.13, revenue of $4.04M misses by $0.02M